In COPD patients, some of the biomarkers investigated by us, e.g., Tenascin-C, fibronectin, ET-1 or NGAL, have been recently shown to be of potential diagnostic or prognostic impact [45,46,47,48]. Here, LCN2 is linked to chronic obstructive pulmonary disease.